查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1566852

乙醯左旋肉鹼 (ALC) 市場：按類型、分銷管道分類：2024-2033 年全球機會分析和產業預測

Acetyl-L Carnitine (ALC) Market By Type (Capsules, Tablets, Others) , By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 211 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

乙醯左旋肉鹼 (ALC) 市場

2023 年乙醯左旋肉鹼 (ALC) 市值為 5,810 萬美元，預計 2024 年至 2033 年複合年成長率為 5.3%，到 2033 年達到 9,750 萬美元。

乙醯左旋肉鹼 (ALC) 是一種在人體內由胺基酸左旋肉鹼合成的天然化合物。 ALC 在細胞能量形成中發揮重要作用，因為它促進脂肪酸轉移到粒線體，脂肪酸在粒線體中被氧化以產生能量。血漿中的酯酶將 ALC 分解為肉鹼，用於脂肪酸傳輸。此外，ALC 也參與乙醯膽鹼的產生，乙醯膽鹼有助於記憶和認知功能。由於其抗氧化特性和對神經細胞健康的支持，ALC 對神經退化性疾病有益。

由於乙醯左旋肉鹼（ALC）是補充品中的重要成分，因此人們對保健補充品的認知和攝入量的提高是乙醯左旋肉鹼（ALC）市場的關鍵促進因素。此外，隨著全球人口結構向老年群體轉變，對支持認知功能和緩解與老齡化相關的健康問題的藥物的需求將激增，導致對 ALC 的需求增加。目前，運動員中 ALC 攝入趨勢正在顯現，這種化合物已被證明在高強度運動表現中能產生積極的效果。 ALC 的正面結果歸因於其在維持體內線粒體乙醯輔酶 A/輔酶 A 比例方面的作用。

然而，在膳食食品中使用 ALC 有多項健康法規，遵守這些法規是一項挑戰。這限制了乙醯左旋肉鹼（ALC）市場的成長。例如，美國健康與營養檢查調查（營養與食品學會的膳食食品標籤資料庫）分析了膳食食品配方中各種成分的使用情況，並制定了嚴格的用量指南。對包括 ALC 在內的營養成分進行嚴格監管對於防止過量攝取的嚴重後果是必要的。據報導，過量攝取攝取 ALC 會導致雙極性情感障礙患者出現高血壓、高三酸甘油酯和精神病。

分部審查

乙醯左旋肉鹼 (ALC) 市場按類型、分銷管道和區域細分。按類型分類，市場分為膠囊、錠劑。依分銷管道分為醫院藥房、藥局和零售藥房以及線上供應商。從區域來看，分析涵蓋北美、歐洲、亞太地區和拉丁美洲/中東/非洲。

主要發現

按類型分類，錠劑領域是 2023 年的最大股東。

按分銷管道分類，2023年藥局和零售藥局細分市場佔據較高市場佔有率。

按地區分類，預計到 2033 年，北美地區的收益將最高。

該報告可以客製化。

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 擴大公司簡介列表
  • 歷史市場資料
  • 主要參與企業的詳細資料（Excel格式，包括位置、聯絡資訊、供應商/供應商網路等）

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 關鍵投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第 4 章 乙醯左旋肉鹼 (ALC) 市場：依類型

  • 市場概況
  • 膠囊
  • 錠劑
  • 其他

第5章乙醯左旋肉鹼（ALC）市場：依分銷管道

  • 市場概況
  • 醫院藥房
  • 藥局和零售藥房
  • 線上提供者

第6章乙醯左旋肉鹼（ALC）市場：依地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國乙醯左旋肉鹼（ALC）市場
    • 加拿大乙醯左旋肉鹼（ALC）市場
    • 墨西哥乙醯左旋肉鹼（ALC）市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 德國乙醯左旋肉鹼（ALC）市場
    • 法國乙醯左旋肉鹼（ALC）市場
    • 英國乙醯左旋肉鹼（ALC）市場
    • 義大利乙醯左旋肉鹼（ALC）市場
    • 西班牙乙醯左旋肉鹼（ALC）市場
    • 其他歐洲乙醯左旋肉鹼 (ALC) 市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 日本乙醯左旋肉鹼（ALC）市場
    • 中國乙醯左旋肉鹼（ALC）市場
    • 印度乙醯左旋肉鹼（ALC）市場
    • 澳洲乙醯左旋肉鹼（ALC）市場
    • 韓國乙醯左旋肉鹼（ALC）市場
    • 其他亞太地區乙醯左旋肉鹼 (ALC) 市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西乙醯左旋肉鹼（ALC）市場
    • 沙烏地阿拉伯乙醯左旋肉鹼（ALC）市場
    • 南非乙醯左旋肉鹼（ALC）市場
    • 其他拉丁美洲/中東/非洲乙醯左旋肉鹼 (ALC) 市場

第7章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第8章 公司簡介

  • Nature's Bounty
  • Swanson
  • Namedsport Srl
  • Intas Pharmaceuticals Ltd.
  • NutriJa Lifesciences
  • Chemkart
  • Foodchem International Corporation
  • SimplySupplements
  • GNC Holdings, LLC
  • Solaray
簡介目錄
Product Code: A108370

Acetyl-L Carnitine (ALC) Market

The acetyl-L carnitine (ALC) market was valued at $58.1 million in 2023 and is projected to reach $97.5 million by 2033, growing at a CAGR of 5.3% from 2024 to 2033.

Acetyl-L-carnitine (ALC) is a natural compound synthesized inside the human body from the amino acid L-carnitine. ALC plays an essential role in cellular energy formation as it facilitates the transfer of fatty acids into the mitochondria, where they are oxidized to produce energy. Plasma esterases break down ALC in the blood into carnitine, which is then utilized for the transmission of fatty acids. In addition, ALC contributes to memory and cognitive function as it is involved in acetylcholine production. The antioxidant properties and nerve cell health support make ALC beneficial in neurodegenerative conditions.

Increase in awareness and uptake of health supplements is a key driver of the acetyl-L carnitine (ALC) market as the compound is an essential element of the supplements. Furthermore, as the demographics shift toward old age groups globally, the demand for ALC is rising due to surge in the requirement for medications that support cognitive function and mitigate age-related health concerns. Currently, the trend of the uptake of ALC is emerging among athletes as the compound has been identified to deliver positive outcomes during high-intensity sports performances. The positive results by ALC are attributed to its role in maintaining the mitochondrial acetyl-CoA/CoA ratio inside the body.

However, the usage of ALC in health supplements is subject to several health regulations, compliance with which is a challenging task. This restrains the growth of the acetyl-L carnitine (ALC) market. For instance, the National Health and Nutrition Examination Survey, a dietary supplement label database, by the Academy of Nutrition and Dietetics in the U.S. has imposed stringent guidelines pertaining to usage quantities of different components present in the formulations of health supplements. Such rigorous regulations over dietary components, including ALC, are required to prevent the severe outcomes of overdose. Overdoses of ALC have been reported to cause high blood pressure, high triglycerides, and psychosis in individuals suffering from bipolar disorder.

Segment Review

The acetyl-L carnitine (ALC) market is segmented into type, distribution channel, and region. On the basis of type, the market is divided into capsules, tablets, and others. As per distribution channel, it is classified into hospital pharmacies, drug stores & retail pharmacies, and online providers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the tablets segment was the highest shareholder in 2023.

As per distribution channel, the drug stores & retail pharmacies segment accounted for a high market share in 2023.

Region wise, North America is projected to be the highest revenue generator by 2033.

Competition Analysis

The major players operating in the global acetyl-L carnitine (ALC) market include Nature's Bounty, Swanson, Namedsport S.r.l., Intas Pharmaceuticals Ltd., NutriJa Lifesciences, Chemkart, Foodchem International Corporation, SimplySupplements , GNC Holdings, LLC, and Solaray. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Type

  • Capsules
  • Tablets
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Providers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Nature's Bounty
    • Swanson
    • Namedsport S.r.l.
    • Intas Pharmaceuticals Ltd.
    • NutriJa Lifesciences
    • Chemkart
    • Foodchem International Corporation
    • SimplySupplements
    • GNC Holdings, LLC
    • Solaray

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ACETYL-L CARNITINE (ALC) MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Capsules
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Tablets
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Others
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: ACETYL-L CARNITINE (ALC) MARKET, BY DISTRIBUTION CHANNEL

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Distribution Channel
  • 5.2. Hospital Pharmacies
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Drug Stores And Retail Pharmacies
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Online Providers
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ACETYL-L CARNITINE (ALC) MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Type
    • 6.2.3. Market Size and Forecast, By Distribution Channel
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Acetyl-L Carnitine (ALC) Market
      • 6.2.5.1. Market Size and Forecast, By Type
      • 6.2.5.2. Market Size and Forecast, By Distribution Channel
    • 6.2.6. Canada Acetyl-L Carnitine (ALC) Market
      • 6.2.6.1. Market Size and Forecast, By Type
      • 6.2.6.2. Market Size and Forecast, By Distribution Channel
    • 6.2.7. Mexico Acetyl-L Carnitine (ALC) Market
      • 6.2.7.1. Market Size and Forecast, By Type
      • 6.2.7.2. Market Size and Forecast, By Distribution Channel
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Type
    • 6.3.3. Market Size and Forecast, By Distribution Channel
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. Germany Acetyl-L Carnitine (ALC) Market
      • 6.3.5.1. Market Size and Forecast, By Type
      • 6.3.5.2. Market Size and Forecast, By Distribution Channel
    • 6.3.6. France Acetyl-L Carnitine (ALC) Market
      • 6.3.6.1. Market Size and Forecast, By Type
      • 6.3.6.2. Market Size and Forecast, By Distribution Channel
    • 6.3.7. UK Acetyl-L Carnitine (ALC) Market
      • 6.3.7.1. Market Size and Forecast, By Type
      • 6.3.7.2. Market Size and Forecast, By Distribution Channel
    • 6.3.8. Italy Acetyl-L Carnitine (ALC) Market
      • 6.3.8.1. Market Size and Forecast, By Type
      • 6.3.8.2. Market Size and Forecast, By Distribution Channel
    • 6.3.9. Spain Acetyl-L Carnitine (ALC) Market
      • 6.3.9.1. Market Size and Forecast, By Type
      • 6.3.9.2. Market Size and Forecast, By Distribution Channel
    • 6.3.10. Rest of Europe Acetyl-L Carnitine (ALC) Market
      • 6.3.10.1. Market Size and Forecast, By Type
      • 6.3.10.2. Market Size and Forecast, By Distribution Channel
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Type
    • 6.4.3. Market Size and Forecast, By Distribution Channel
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. Japan Acetyl-L Carnitine (ALC) Market
      • 6.4.5.1. Market Size and Forecast, By Type
      • 6.4.5.2. Market Size and Forecast, By Distribution Channel
    • 6.4.6. China Acetyl-L Carnitine (ALC) Market
      • 6.4.6.1. Market Size and Forecast, By Type
      • 6.4.6.2. Market Size and Forecast, By Distribution Channel
    • 6.4.7. India Acetyl-L Carnitine (ALC) Market
      • 6.4.7.1. Market Size and Forecast, By Type
      • 6.4.7.2. Market Size and Forecast, By Distribution Channel
    • 6.4.8. Australia Acetyl-L Carnitine (ALC) Market
      • 6.4.8.1. Market Size and Forecast, By Type
      • 6.4.8.2. Market Size and Forecast, By Distribution Channel
    • 6.4.9. South Korea Acetyl-L Carnitine (ALC) Market
      • 6.4.9.1. Market Size and Forecast, By Type
      • 6.4.9.2. Market Size and Forecast, By Distribution Channel
    • 6.4.10. Rest of Asia-Pacific Acetyl-L Carnitine (ALC) Market
      • 6.4.10.1. Market Size and Forecast, By Type
      • 6.4.10.2. Market Size and Forecast, By Distribution Channel
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Type
    • 6.5.3. Market Size and Forecast, By Distribution Channel
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Acetyl-L Carnitine (ALC) Market
      • 6.5.5.1. Market Size and Forecast, By Type
      • 6.5.5.2. Market Size and Forecast, By Distribution Channel
    • 6.5.6. Saudi Arabia Acetyl-L Carnitine (ALC) Market
      • 6.5.6.1. Market Size and Forecast, By Type
      • 6.5.6.2. Market Size and Forecast, By Distribution Channel
    • 6.5.7. South Africa Acetyl-L Carnitine (ALC) Market
      • 6.5.7.1. Market Size and Forecast, By Type
      • 6.5.7.2. Market Size and Forecast, By Distribution Channel
    • 6.5.8. Rest of LAMEA Acetyl-L Carnitine (ALC) Market
      • 6.5.8.1. Market Size and Forecast, By Type
      • 6.5.8.2. Market Size and Forecast, By Distribution Channel

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Nature's Bounty
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Swanson
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Namedsport S.r.l.
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Intas Pharmaceuticals Ltd.
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. NutriJa Lifesciences
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Chemkart
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Foodchem International Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. SimplySupplements
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. GNC Holdings, LLC
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Solaray
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments